China Money Network
Login
Join

Chinese NASH-Focused Biotech Firm Sciwind Biosciences Raises $29M Series A Round

  • February 14, 2019 — 02:09 CST

This Data Is Locked!

This area is available only to Subscribers.

Sciwind Biosciences, a Chinese drug research and development company for metabolic diseases, announced on Wednesday that it has raised a nearly RMB200 million (US$29.58 million)... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: